Invention Grant
- Patent Title: Pyrimidine compound
- Patent Title (中): 嘧啶化合物
-
Application No.: US12933137Application Date: 2010-03-29
-
Publication No.: US08524727B2Publication Date: 2013-09-03
- Inventor: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
- Applicant: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2009-082282 20090330
- International Application: PCT/JP2010/055506 WO 20100329
- International Announcement: WO2010/113834 WO 20101007
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505
Abstract:
A novel and excellent method for preventing and/or treating diseases related to a cannabinoid type 2 receptor, based on an agonistic action on a cannabinoid type 2 receptor. It was found that a hetero ring derivative mainly having two substituents, for example, a pyrimidine-5-carboxamide derivative having a substituent amino group at the 2-position, exhibits a potent agonistic action on a cannabinoid type 2 receptor, and can be an agent for preventing and/or treating diseases related to a cannabinoid type 2 receptor such as inflammatory diseases, pain, and the like.
Public/Granted literature
- US20110053912A1 PYRIMIDINE COMPOUND Public/Granted day:2011-03-03
Information query
IPC分类:
